Immunomodulatory lectin-like peptides for fish erythrocytes-targeting as potential antiviral drug delivery platforms

One of the challenges of science in disease prevention is optimizing drug and vaccine delivery. Until now, many strategies have been employed in this sector, but most are quite complex and labile. To overcome these limitations, great efforts are directed to coupling drugs to carriers, either of natu...

Descripción completa

Detalles Bibliográficos
Autores: Salvador-Mira, Maria, Chico, Veronica|||0000-0001-6983-2786, Arostica, Mónica, Guzmán, Fanny|||0000-0002-7829-0568, Roher Armentia, Nerea|||0000-0002-6659-4038, Perez Garcia-Estañ, Luis|||0000-0003-4078-8763, Ortega-Villaizan, Maria del Mar|||0000-0003-2065-0601
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:255160
Acceso en línea:https://ddd.uab.cat/record/255160
https://dx.doi.org/urn:doi:10.3390/ijms222111821
Access Level:acceso abierto
Palabra clave:Peptide
Red blood cells
Erythrocyte
Drug delivery
Ligand
Prophylactic
Therapeutic
Cell-targeting
Lectin
Fish
Descripción
Sumario:One of the challenges of science in disease prevention is optimizing drug and vaccine delivery. Until now, many strategies have been employed in this sector, but most are quite complex and labile. To overcome these limitations, great efforts are directed to coupling drugs to carriers, either of natural or synthetic origin. Among the most studied cell carriers are antigen-presenting cells (APCs), however, red blood cells (RBCs) are positioned as attractive carriers in drug delivery due to their abundance and availability in the body. Furthermore, fish RBCs have a nucleus and have been shown to have a strong involvement in modulating the immune response. In this study, we evaluated the binding of three peptides to rainbow trout RBCs, two lectin-like peptides and another derived from Plasmodium falciparum membrane protein, in order to take advantage of this peptide-RBCs binding to generate tools to improve the specificity, efficacy, immunostimulatory ef-fect, and safety of the antiviral therapeutic or prophylactic administration systems currently used.